NextCure, Inc.
NXTC
$8.21
-$0.07-0.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -20.76% | 10.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.87% | 3.57% | |||
| Operating Income | 0.87% | -3.57% | |||
| Income Before Tax | -52.02% | -3.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -52.02% | -3.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -52.02% | -3.82% | |||
| EBIT | 0.87% | -3.57% | |||
| EBITDA | 0.78% | -4.58% | |||
| EPS Basic | -50.01% | 21.11% | |||
| Normalized Basic EPS | 1.14% | 21.11% | |||
| EPS Diluted | -50.01% | 21.11% | |||
| Normalized Diluted EPS | 1.14% | 21.11% | |||
| Average Basic Shares Outstanding | 1.35% | 31.60% | |||
| Average Diluted Shares Outstanding | 1.35% | 31.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||